Search Results

Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.

• Authors : Atallah-Yunes SA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Habermann TM

• Source: British journal of haematology [Br J Haematol] 2024 Apr 05. Date of Electronic Publication: 2024 Apr 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Genomic characterization of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli from urban wastewater in Australia.

• Authors : Rahman Z; School of Biological, Earth and Environmental Sciences, Centre for Marine Science and Innovation, UNSW Sydney, Sydney, New South Wales, Australia.; McLaws ML

Subjects: Escherichia coli Infections* ; Carbapenem-Resistant Enterobacteriaceae*/Carbapenem-Resistant Enterobacteriaceae*/Carbapenem-Resistant Enterobacteriaceae*/genetics; Humans

• Source: MicrobiologyOpen [Microbiologyopen] 2024 Apr; Vol. 13 (2), pp. e1403.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101588314 Publication Model: Print Cited Medium:

Record details

Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant.

• Authors : Scott W; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Wong IGY

Subjects: Cystic Fibrosis Transmembrane Conductance Regulator*/Cystic Fibrosis Transmembrane Conductance Regulator*/Cystic Fibrosis Transmembrane Conductance Regulator*/genetics ; Cystic Fibrosis*; Child

• Source: American journal of medical genetics. Part A [Am J Med Genet A] 2024 Apr; Vol. 194 (4), pp. e63489. Date of Electronic Publication: 2023 Dec 06.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited

Record details

Hot topics in allergen immunotherapy, 2023: Current status and future perspective.

• Authors : Zemelka-Wiacek M; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.; Agache I

Subjects: Artificial Intelligence* ; Hypersensitivity*/Hypersensitivity*/Hypersensitivity*/diagnosis ; Hypersensitivity*/Hypersensitivity*/Hypersensitivity*/therapy

• Source: Allergy [Allergy] 2024 Apr; Vol. 79 (4), pp. 823-842. Date of Electronic Publication: 2023 Nov 20.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium:

Record details

Management of bleeding during dental implant surgery using a novel implant with an abbreviated drilling protocol: A clinical report.

• Authors : Babayan M; Former Resident, Division of Prosthodontics, University of Connecticut Health Center, Farmington, Connecticut, USA.; Bidra AS

Subjects: Dental Implants* ; Immediate Dental Implant Loading*; Humans

• Source: Journal of prosthodontics : official journal of the American College of Prosthodontists [J Prosthodont] 2024 Mar; Vol. 33 (3), pp. 206-211. Date of Electronic Publication: 2023 SepPublisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9301275 Publication Model: Print-Electronic Cited

Record details

Expanding the phenotype of UPF3B-related disorder: Case reports and literature review.

• Authors : Romano F; Clinical Genomics and Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.; Haanpää MK

• Source: American journal of medical genetics. Part A [Am J Med Genet A] 2024 Feb 06, pp. e63534. Date of Electronic Publication: 2024 Feb 06.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited

Record details

How to improve treatment-free remission eligibility in chronic myeloid leukaemia?

• Authors : Costa A; Hematology Unit, Department of Medical Sciences and Public Health, Businco Hospital, University of Cagliari, Cagliari, Italy.; Breccia M

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy; Humans

• Source: British journal of haematology [Br J Haematol] 2024 Feb; Vol. 204 (2), pp. 434-448. Date of Electronic Publication: 2023 Dec 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Effectiveness of novel oral hygiene instruction avoiding inattentional blindness using an application for unique plaque control record calculation: A randomized clinical trial.

• Authors : Mitani A; Department of Periodontology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.; Matsuura T

• Source: Journal of periodontal research [J Periodontal Res] 2024 Jan 08. Date of Electronic Publication: 2024 Jan 08.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0055107 Publication Model: Print-Electronic Cited

Record details

Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions.

• Authors : Molica S; Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull University NHS Trust, Hull, UK.; Tam C

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism

• Source: Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3238. Date of Electronic Publication: 2023 Nov 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium:

Record details

Clinical and genetic characterization of a Chinese family with pontocerebellar hypoplasia type 7.

• Authors : Wu ZF; Department of Pediatrics, Second Affiliated Hospital of Army Medical University, Chongqing, China.; Lv KL

Subjects: Cerebellar Diseases* ; Intellectual Disability*/Intellectual Disability*/Intellectual Disability*/genetics; Humans Pontocerebellar Hypoplasia

• Source: American journal of medical genetics. Part A [Am J Med Genet A] 2024 Jan; Vol. 194 (1), pp. 46-52. Date of Electronic Publication: 2023 Aug 23.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited

Record details